CHARLOTTE, N.C., February 19, 2014 -- NYU Langone Medical Center and SonaCare Medical, LLC (SonaCare Medical), a global leader in minimally invasive focused therapeutic ultrasound technologies, announced a collaboration to develop tools and clinical procedures based on the use of advanced focused therapeutic ultrasound technology. Together, NYU Langone Medical Center and SonaCare Medical anticipate providing physician education, training and technology development across multiple disciplines. 

Novel SonaSurgery Treatment, Using "Sound Based Therapy," Will Be Introduced

Charlotte, N.C., January 7, 2014 -- SonaCare Medical, LLC (SonaCare Medical), a leader in minimally invasive high intensity focused ultrasound (HIFU) technology, will present at the upcoming J.P. Morgan Healthcare Conference being held in San Francisco, CA.  Michael Klein, Chief Executive Officer of SonaCare Medical, will present on Tuesday, January 14, 2014 at 4:30 p.m. PST.

Vincent Prajka Brings Significant Financial, Operational and Administrative Expertise as the Company Nears U.S. Commercialization of its High Intensity Focused Ultrasound (HIFU) Treatment Platform

Charlotte, N.C. - September 4, 2013 -- SonaCare Medical, a leader in minimally invasive high intensity focused ultrasound (HIFU) technology, announced today that Vincent (Vinny) Prajka has joined as Chief Financial Officer.  

Results demonstrate that MRI-US registration and fusion software can inform the planning of new tissue preserving treatments for prostate cancer using the Sonablate® 500 system

CHARLOTTE, N.C. and LONDON, Thursday, July 25, 2013 – Study results published in the current issue of British Journal of Urology International (10.1111/bju.12223) demonstrate that new software to register and fuse information from magnetic resonance imaging (MRI) and ultrasound (US) images enables intraoperative visualization of tumors, not ordinarily seen in a US image. This technology has the potential to support new tissue-preserving treatments for prostate cancer, such as focal therapy.

With Successful Launch of Sonatherm® HIFU Surgical Ablation System at AUA, SonaCare Medical Delivers on the Promise of Image Guided Minimally Invasive Technology

SAN DIEGO, Thursday, May 23, 2013 - The need to add tissue preserving therapies to the prostate cancer treatment continuum was highlighted prominently at the 108th Annual Meeting of the American Urological Association (AUA), in San Diego.  According to SonaCare Medical, a leader in minimally invasive high intensity focused ultrasound (HIFU) technology, the need for image-guided technologies to better identify and localize disease, and for urologists to consider minimally invasive ablative treatments, was addressed in the Opening Session, the Dr. W. Whitmore Memorial Lecture, and multiple sessions throughout the AUA meeting.

Page 7 of 9

HIFU company


10130 Perimeter Pkwy, Suite 250
      Charlotte, NC 28216

(888) 874-4384

Mon - Fri: 9:00 - 5:00

Latest News

23 May 2017

C-code goes into effect on July 1, 2017 affording greater opportunity to prostate patients in the United States Charlotte, NC, May 23, 2017 – SonaCare Medical, leading developer and manufacturer...

11 April 2017

Charlotte, NC (PR Newswire) April 11th, 2017 - SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces the launch of an International Sonablate HIFU...